Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cancer Research

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12231536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wound repair

  2017cited by this paper
• Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins

  2004cited by this paper
• Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

  2002cited by this paper
• Reactive stroma in prostate cancer progression.

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Epithelial-stromal interactions and tumor progression: meeting summary and future directions.

  2001cited by this paper
• Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.

  2001cited by this paper
• Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma

  2001cited by this paper
• Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.

  2001cited by this paper
• Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer*

  2001cited by this paper
• Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

  2000cited by this paper
• Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer.

  2000cited by this paper
• The influence of the microenvironment on the malignant phenotype.

  2000cited by this paper
• Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.

  1999cited by this paper
• Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.

  1999cited by this paper
• Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo.

  1999cited by this paper
• Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts*

  1999cited by this paper
• Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

  1999cited by this paper
• Localization of Transforming Growth Factor-β1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma Tissues

  1998cited by this paper
• Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

  1998cited by this paper
• Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.

  1998cited by this paper
• Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.

  1998cited by this paper
• The Role of Stroma in Breast Carcinoma Growth In Vivo

  1998cited by this paper
• Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression?

  1998influential reference
• What Might A Stromal Response Mean to Prostate Cancer Progression?

  1998cited by this paper
• Stimulative Effect of Transforming Growth Factor‐β on Collagen Synthesis by Human Prostatic Stromal Cells In Vitro

  1997cited by this paper
• Down‐regulation of protein and mRNA expression for transforming growth factor‐β (TGF‐β1) type I and type II receptors in human prostate cancer

  1997cited by this paper
• In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

  1997cited by this paper
• Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.

  1997cited by this paper
• Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors.

  1997cited by this paper
• Expression of fibronectin and tenascin‐C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas

  1997cited by this paper
• Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.

  1996cited by this paper
• Normal Development and Carcinogenesis of the Prostate

  1996cited by this paper
• Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.

  1996cited by this paper
• Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.

  1996cited by this paper
• Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion.

  1996cited by this paper
• Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.

  1996cited by this paper
• Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.

  1995cited by this paper
• The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells.

  1995cited by this paper
• Regulation of differentiation of vascular smooth muscle cells.

  1995cited by this paper
• Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms.

  1995cited by this paper
• The role of fibroblasts in tumor behavior

  1995cited by this paper
• Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.

  1995cited by this paper
• Fibroblast activation protein: Purification, epitope mapping and induction by growth factors

  1994cited by this paper
• The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development.

  1994cited by this paper
• Fresh tissue harvest for research from prostatectomy specimens

  1994cited by this paper
• The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations.

  1994cited by this paper
• Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

  1993cited by this paper
• Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma.

  1993influential reference
• Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia.

  1993cited by this paper
• Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.

  1992cited by this paper
• Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium.

  1991cited by this paper
• Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

  1990cited by this paper
• Transforming growth factor‐α

  1990influential reference
• Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations.

  1990influential reference
• Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.

  1990cited by this paper
• Transforming Growth Factor‐β

  1990cited by this paper
• Transcripts for transforming growth factors in human breast cancer: clinical correlates.

  1990cited by this paper
• Tenascin is a stromal marker for epithelial malignancy in the mammary gland.

  1987cited by this paper
• Production of transforming growth factors by human colon cancer lines.

  1986cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper
• Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

  1986cited by this paper
• Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

  year unknowncited by this paper

• Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip

  2026cites this paper
• Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array-based cytokine profiling.

  2026cites this paper
• Cell type composition in bulk prostate cancer tissue is a prognostic biomarker

  2026cites this paper
• Prostate Cancer Characterization Based on Rapid SHG Imaging of Collagen Fiber Combined With Denoising Algorithm

  2026cites this paper
• Reactive Stroma as a Transversal Prognostic Biomarker for Metastasis in Breast Cancer: Integration of Digital Histopathology and Transcriptomic Profiling

  2026cites this paper
• Single‐Cell Morphomechanics of Prostate Cancer‐Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome

  2026cites this paper
• Cancer-associated fibroblast subtypes in the tumor microenvironment of prostate cancer and associations to patient outcomes.

  2026cites this paper
• Biomechanical Forces in Prostate Cancer: Current Insights and Future Directions.

  2026cites this paper
• Hierarchical Micro-Nano Surface Roughness Wax-Impregnated Cotton Fabrics Platform for Cell-Based Diagnostics

  2025cites this paper
• Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer

  2025cites this paper
• Quantitative assessment of biomechanical changes in oral lesions at different cancerous stages using optical coherence elastography

  2025cites this paper
• CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt/β-catenin and SDF-1/CXCR4 pathways in castration-resistant prostate cancer

  2025cites this paper
• Differential effects of jaboticaba peel extract administration on PCa progression in TRAMP mice depend on the androgenic status of the prostatic milieu and are driven by angiogenesis regulation.

  2025cites this paper
• Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate.

  2025cites this paper
• Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection

  2025cites this paper
• How to rejuvenate the prostate damaged by cancer

  2025cites this paper
• Three-Dimensional Shear-Wave Viscoelastographic Estimation by System Identification for Prostate Cancer Localization.

  2025cites this paper
• Pathology of a Canine Model of Localized Prostate Carcinoma

  2025cites this paper
• TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance

  2025cites this paper
• Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication.

  2025cites this paper
• The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system

  2025cites this paper
• Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities

  2025cites this paper
• Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates

  2025cites this paper
• Targeting Cancer-Associated Fibroblasts in Prostate Cancer: Recent Advances and Therapeutic Opportunities

  2025cites this paper
• Biophysical perspectives to understanding cancer-associated fibroblasts

  2024cites this paper
• Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention

  2024cites this paper
• Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk

  2024cites this paper
• Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

  2024cites this paper
• Microfluidic-based human prostate-cancer-on-chip

  2024cites this paper
• Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer

  2024cites this paper
• Non-Invasive Diagnosis of Prostate Cancer and High-Grade Prostate Cancer Using Multiparametric Ultrasonography and Serological Examination.

  2024cites this paper
• Hyaluronan-Based Hydrogels for 3D Modeling of Tumor Tissues

  2024cites this paper
• The multifaceted role of the stroma in the healthy prostate and prostate cancer

  2024cites this paper
• Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis

  2024influential citation
• WSAVA guidelines for the control of reproduction in dogs and cats.

  2024cites this paper
• Modifying the electrical, optical, and magnetic properties of cancer cells: A comprehensive approach for cancer management

  2024cites this paper
• Stromal androgen signaling governs essential niches in supporting prostate development and tumorigenesis

  2024cites this paper
• Forces at play: exploring factors affecting the cancer metastasis

  2024cites this paper
• AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production

  2024cites this paper
• Can Shockwave Treatment Elicit a Molecular Response to Enhance Clinical Outcomes in Pressure Ulcers? The SHOck Waves in wouNds Project

  2024cites this paper
• Differential tempol effects in prostatic cancer: angiogenesis and short- and long-term treatments

  2024cites this paper
• Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate

  2024cites this paper
• The activated complement pathway in the fibrous process of benign prostatic hyperplasia

  2023cites this paper
• The role of hypoxia on prostate cancer progression and metastasis

  2023cites this paper
• Preliminary study of some of the main intratumor stroma components in gastric carcinomas.

  2023cites this paper
• Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.

  2023cites this paper
• Extracellular Mechanical Stimuli Alters the Metastatic Progression of Prostate Cancer Cells within 3D Tissue Matrix

  2023cites this paper
• Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model

  2023cites this paper
• Toxicoproteomics of Mono(2-ethylhexyl) phthalate and Perfluorooctanesulfonic Acid in Models of Prostatic Diseases.

  2023cites this paper
• Fibroblasts as Playmakers of Cancer Progression: Current Knowledge and Future Perspectives

  2023cites this paper
• Elastin-like Recombinamer Hydrogels as Platforms for Breast Cancer Modeling

  2023cites this paper
• Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer

  2023influential citation
• Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia

  2023cites this paper
• Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells

  2023cites this paper
• Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies

  2023cites this paper
• Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment

  2023cites this paper
• New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer

  2023cites this paper
• Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis

  2023cites this paper
• Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance

  2023cites this paper
• Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

  2023cites this paper
• Lobe-specific responses of TRAMP mice dorsolateral prostate following celecoxib and nintedanib therapy

  2023influential citation
• Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions

  2023cites this paper
• Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.

  2022cites this paper
• Targeting tumor innervation: premises, promises, and challenges

  2022cites this paper
• Editorial Comment to Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer

  2022cites this paper
• Collagen-Specific Molecular Magnetic Resonance Imaging of Prostate Cancer

  2022cites this paper
• High-Grade Desmoplastic Foamy Gland Prostatic Adenocarcinoma.

  2022cites this paper
• “Stromal cells in prostate cancer pathobiology: friends or foes?”

  2022influential citation
• Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts

  2022cites this paper
• The expression of stromal biomarkers in small papillary thyroid carcinomas

  2022cites this paper
• The prostate stromal transcriptome in aggressive and lethal prostate cancer.

  2022cites this paper
• Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones

  2022cites this paper
• Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment

  2022cites this paper
• MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

  2022cites this paper
• Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer

  2022influential citation
• A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.

  2022cites this paper
• Androgen receptor variant-7 regulation by tenascin-c induced src activation

  2022cites this paper
• Nanoparticles targeted to fibroblast activation protein outperform PSMA for MRI delineation of primary prostate tumours

  2022cites this paper
• Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation

  2022cites this paper
• The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?

  2022cites this paper
• Title: Preclinical assessment of Fibroblast Activation Protein-specific MRI as an alternative 1 to PSMA for image-guided focal therapy of prostate cancer

  2022cites this paper
• The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention

  2022cites this paper
• Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer

  2022cites this paper
• The dynamic roles of the bladder tumour microenvironment

  2022cites this paper
• The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

  2022cites this paper
• Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition

  2021cites this paper
• Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient‐derived fibroblasts

  2021cites this paper
• Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI

  2021cites this paper
• Characterisation of Collagen Re-Modelling in Localised Prostate Cancer Using Second-Generation Harmonic Imaging and Transrectal Ultrasound Shear Wave Elastography

  2021cites this paper
• Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients

  2021cites this paper
• Fibroblast heterogeneity in prostate carcinogenesis.

  2021cites this paper
• Stroma‐derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer

  2021cites this paper
• The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment

  2021cites this paper
• The Role of Tumor Microenvironment and Exosomes in Dormancy and Relapse.

  2021cites this paper
• ELF3 mediates IL‐1α induced differentiation of mesenchymal stem cells to inflammatory iCAFs

  2021cites this paper
• Cellular senescence as a possible link between prostate diseases of the ageing male

  2021cites this paper
• Phenotypic screening system using three-dimensional (3D) culture models for natural product screening

  2021cites this paper
• Prostate cancer reprogramming and dedifferentiation into induced pluripotent stem cells

  2021cites this paper
• A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells

  2021cites this paper
• Fibrin and Transforming Growth Factor Alpha Affect Prostatic Smooth Muscle Cell's Phenotype and Motility

  2021cites this paper